Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers

NCT06940687 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-11

No results posted yet for this study

Summary

This study aims to investigate the neurophysiological effects of live music on individuals with early Alzheimer's Disease (AD), dementia, and/or mild cognitive impairment (MCI) and their caregivers. Heart rate (HR), heart rate variability (HRV), and brain activity will be measured as participant-caregiver dyads listen to preferred and improvised music performed by professional musicians. Investigators will leverage various measurement techniques including, but not limited to, electroencephalography (EEG), behavioral, surveys, and physiological monitoring to study the impact of live music on anxiety in AD and inter-dyad synchrony.

Conditions

Interventions

BEHAVIORAL

Pre-recorded Music Session

A pre-recorded concert session

BEHAVIORAL

Live Music Session

A 45-minute live music performance

Sponsors & Collaborators

  • Renée Fleming Foundation

    collaborator UNKNOWN
  • Yale University School of Medicine, Department of Psychiatry

    collaborator UNKNOWN
  • Howard University

    collaborator OTHER
  • NeuroArts Blueprint Initiative

    collaborator UNKNOWN
  • Yale University

    lead OTHER

Principal Investigators

  • AZA Allsop, MD, PhD · Yale University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-28
Primary Completion
2026-03-22
Completion
2026-03-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06940687 on ClinicalTrials.gov